ATC Group: G03AD02 Ulipristal

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G03AD02 in the ATC hierarchy

Level	Code	Title
1	G	Genito urinary system and sex hormones
2	G03	Sex hormones and modulators of the genital system
3	G03A	Hormonal contraceptives for systemic use
4	G03AD	Emergency contraceptives
5	G03AD02	Ulipristal

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route	Amount
ORAL - Oral	30 mg

Active ingredients in G03AD02

Active Ingredient	Description
Ulipristal	Ulipristal is an orally-active synthetic selective progesterone receptor modulator which acts via high-affinity binding to the human progesterone receptor. When used for emergency contraception the mechanism of action is inhibition or delay of ovulation via suppression of the luteinising hormone (LH) surge. Pharmacodynamic data show that even when taken immediately before ovulation is scheduled to occur (when LH has already started to rise), ulipristal acetate is able to postpone follicular rupture for at least 5 days.